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• First review of behaviour change techniques to prevent postpartum smoking relapse.• Six promising behaviour change techniques (BCTs) were frequently coded.• BCTs were problem solving, social support, information about consequences.• How to perform a behaviour and reduce negative emotions were also promising BCTs.
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A B S T R A C T
Introduction: There is no routine support to prevent postpartum smoking relapse, due to lack of effective in-
terventions. Previous reviews have identified behaviour change techniques (BCTs) within pregnancy cessation
trials to specify which components might be incorporated into more effective interventions, but no reviews have
identified BCTs for prevention of smoking relapse postpartum. We reviewed BCTs and potential delivery modes,
to inform future interventions.
Methods: We searched Medline and EMBASE from January 2015–May 2017; and identified trials published
before 2015 by handsearching systematic reviews. We included RCTs where: i) ≥1 intervention component
aimed to maintain smoking abstinence versus a less intensive intervention; ii) participants included pregnant or
postpartum smoking quitters; iii) smoking status was reported in the postpartum period. We extracted trial
characteristics and used the Behaviour Change Technique Taxonomy v1 to extract BCTs. We aimed to identify
‘promising’ BCTs i.e. those frequently occurring and present in ≥2 trials that demonstrated long-term effec-
tiveness (≥6months postpartum). Data synthesis was narrative.
Results: We included 32 trials, six of which demonstrated long-term effectiveness. These six trials used self-help,
mainly in conjunction with counselling, and were largely delivered remotely. We identified six BCTs as pro-
mising: ‘problem solving’, ‘information about health consequences’, ‘information about social and environmental
consequences’, ‘social support’, ‘reduce negative emotions’ and ‘instruction on how to perform a behaviour’.
Conclusions: Future interventions to prevent postpartum smoking relapse might include these six BCTs to
maximise effectiveness. Tailored self-help approaches, with/without counselling, may be favourable modes of
delivery of BCTs.
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1. Introduction
Smoking in pregnancy or postpartum remains a major preventable
cause of maternal and infant mortality and morbidity (DoH, 2017).
Pregnancy acts as a strong motivator for smoking cessation, with more
women quitting during pregnancy than at any other time in the life
course. Indeed, it is estimated that up to 49% of women are able to
‘spontaneously quit’ before their first antenatal appointment
(Chamberlain, O'Mara-Eves, Porter, et al., 2017) due to factors such as
maternal concerns for the health of the unborn baby (Flemming,
McCaughan, Angus, & Graham, 2015; Notley, Blyth, Craig, Edwards, &
Holland, 2015). Pregnant women can be considered a particularly
vulnerable population, since not only are they themselves at risk of
harm from tobacco smoke, but there are also increased health risks to
the developing fetus and to infants born to smoking mothers. Cessation
support, including the UK NHS Smokefree services and provision of
carbon monoxide monitoring, are effective and cost effective ways to
support pregnant smokers to quit (NICE, 2010). Most women who quit
smoking during pregnancy wish to remain abstinent, but a high pro-
portion return to smoking postpartum (Chamberlain et al., 2017; Jones,
Lewis, Parrott, Wormall, & Coleman, 2016; Lumley et al., 2009).
Postpartum women are particularly vulnerable to smoking relapse due
to factors such as perception of no longer needing to protect the baby,
stress of dealing with a new infant, lack of confidence in remaining quit,
nicotine dependence, living with a smoking partner, and a desire to
return to their pre-pregnancy identity (Flemming et al., 2015; Notley
et al., 2015; Orton, Coleman, Coleman-Haynes, & Ussher, 2018; Riaz,
Lewis, Naughton, & Ussher, 2018). Rates of return to smoking in the
literature vary due to specific population characteristics and variation
in success of any provided intervention (Fang, Goldstein, Butzen, et al.,
2004; Jones et al., 2016). Recent data estimates that up to 76% of
spontaneous quitters restart smoking postpartum (Jones et al., 2016).
For women receiving cessation support; who may be more addicted or
have weaker beliefs about the dangers of smoking; rates may be higher
(Chamberlain et al., 2017; Jones et al., 2016; Lumley et al., 2009). In
randomised clinical trials of within–pregnancy smoking cessation in-
terventions, secondary analysis using point-prevalence data estimated
that across trials, the mean proportion of women smoking at the end of
pregnancy was 87%, rising to 94% six months later, suggesting the
majority of smoking cessation trial participants continue to smoke both
throughout pregnancy and after childbirth (Jones et al., 2016).
Return to smoking postpartum has substantial health and cost im-
plications, thus reducing exposure to smoke in pregnancy is an im-
portant goal worldwide (WHO, 2013). In the UK alone, the annual cost
to the NHS of continuing to smoke in pregnancy is estimated to be as
high as £64 million for treating health related problems for mothers;
and costs for treating mortality and morbidity of infants (aged
0–12months) due to maternal smoking an estimated further £23.5
million (Godfrey, Pickett, Parrott, Mdege, & Eapen, 2010). Sustained
smoking abstinence postpartum has significant health benefits for the
mother and wider family due to reduced exposure to second hand
smoke. Quitting smoking before the age of 30 avoids> 97% of the
excess mortality caused by smoking, due to lower risks of cancers,
coronary heart disease and cerebrovascular disease (Pirie, Peto, Reeves,
Green, & Beral, 2013). Infants exposed to second hand smoke have a
higher incidence of sudden infant death, respiratory conditions in-
cluding asthma, bronchitis and pneumonia, and other infections such as
middle ear disease and meningitis (RCP, 2010). Furthermore, children
of smoking mothers are twice as likely to become smokers themselves,
perpetuating the cycle (Leonardi-Bee, Jere, & Britton, 2011). The pre-
valence of smoking during pregnancy is higher in more disadvantaged
groups (Chamberlain et al., 2017; Coleman, Chamberlain, Davey,
Cooper, & Leonardi-Bee, 2015) and being less well educated has been
identified as an important predictor of relapse postpartum (Orton et al.,
2018). Despite these inequalities, health and cost implications; there is
no routine provision of support to prevent relapse due to a lack of
evidence-based interventions (Hajek et al., 2013). There is thus a clear
need to develop an effective intervention to prevent return to smoking
in postpartum women.
A number of interventions for relapse prevention in pregnancy and
maintenance into the postpartum period have been developed; with
modest success for those incorporating counselling, health education
and/or financial incentives (Chamberlain et al., 2017). Behavioural
change interventions are complex in nature, consisting of multiple
components designed to affect change (Craig et al., 2008). In order to
describe active ingredients (components) of interventions, Michie and
colleagues developed the Behaviour Change Technique Taxonomy v1
(BCTTv1) (Michie et al., 2015; Michie, Richardson, Johnston, et al.,
2013). They propose that by identifying individual behaviour change
techniques (BCTs) within interventions, it is possible to specify how
interventions operate and therefore what components might be in-
corporated into new and more effective interventions (Michie et al.,
2015). Other reviews have identified BCTs for a range of behaviour
change interventions including smoking cessation support for general
smokers (Lorencatto, West, Seymour, & Michie, 2013; West, Walia,
Hyder, Shahab, & Michie, 2010) and for smoking cessation in preg-
nancy (Campbell, Fergie, Coleman-Haynes, et al., 2018; Lorencatto,
West, & Michie, 2012); but no reviews have identified BCTs for smoking
relapse prevention in the postpartum period. We used the BCTTv1
taxonomy (Michie et al., 2013) to identify BCT components which
could be considered ‘promising, or likely to be effective in future in-
terventions to maintain smoking abstinence postpartum. We also re-
viewed the characteristics (mode of delivery and fidelity) of smoking
relapse prevention interventions in order to understand how these
‘promising’ BCTs might be best delivered.
2. Methods
2.1. Types of trials
We included randomised controlled trials of interventions where at
least one component was designed to maintain smoking abstinence,
versus a less intensive intervention or usual care. Participants were
generally healthy pregnant or postpartum women who were recent
smoking quitters (or a mixed population of recent quitters and smokers
at baseline). Trials had to report smoking status (self-report or bio-
chemically validated) in the postpartum period (beyond delivery).
Trials not published in English were excluded due to the detailed in-
tervention information required. Our review was registered on the
PROSPERO international prospective register of systematic reviews
(CRD42018075677).
2.2. Searches
We searched Medline and EMBASE from 1st January 2015 to 9th
May 2017, to replicate and update the search strategy used by Jones
and colleagues (Jones et al., 2016) in a published systematic review of
restarting smoking in the postpartum period. Keywords included:
pregnancy, antenatal, prenatal, childbirth, postnatal, postpartum,
breastfeeding, fetus, newborn, infant, tobacco, smoking, smoking ces-
sation, and relapse. The full search strategy is published in Jones.
(Jones et al., 2016)
Randomised controlled trials published prior to 2015 were identi-
fied by handsearching Jones (Jones et al., 2016) and other recent
pertinent systematic reviews of smoking cessation in pregnancy
(Chamberlain et al., 2017; Coleman et al., 2015) and postpartum re-
lapse prevention interventions (Notley et al., 2015; Orton et al., 2018).
2.3. Selection of trials
One author (TJB) screened citations on the basis of title and ab-
stract, and also using tables of study characteristics when
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handsearching. A second reviewer (IG) independently screened 10% of
titles and abstracts for studies that appeared to be relevant to the re-
view. Disagreement rate was not formally measured, but any dis-
agreements were resolved by consensus. Where it was unclear if a study
met our inclusion criteria, the full-text was collected and assessed. Each
full-text article was assessed for inclusion using an inclusion/exclusion
log. For excluded studies, the reason for exclusion was recorded at full-
text assessment.
2.4. Data extraction
We identified BCTs targeting smoking behaviour, i.e. BCTs included
to maintain smoking abstinence, or to promote smoking cessation to-
gether with maintaining smoking abstinence. The BCTTv1 was used to
extract BCTs by assigning BCT codes to appropriate sections of trial
articles (Michie et al., 2013). Two researchers (TJB and CN) completed
online training in BCTTv1 use (www.bct-taxonomy.com). To ensure
consistency in data recording, data extraction of BCTs was duplicated
independently at a level of 10%, with any disagreements resolved by
discussion or the involvement of an expert third reviewer (WH) who co-
authored the BCTTv1 (Michie et al., 2013; Michie et al., 2015). To
ensure any relevant BCTs were captured, we extracted BCTs whether
they were definitely (coded ++) or probably (coded +) present, fol-
lowing BCTTv1 coding principles (www.bct-taxonomy.com). We cal-
culated frequency of occurrence of BCTs across trials to define a list of
‘promising’ BCTs, most likely to be effective in relapse prevention in-
terventions. We defined a BCT as ‘promising’ if it was present in at least
two long-term effective interventions, as in Lorencatto (Lorencatto
et al., 2012), and where frequency in all included trials, regardless of
trial effectiveness, was highest (present in ≥25% interventions). We
defined long-term effective interventions as those finding statistically
significant (p < .05 where reported) differences in smoking abstinence
between the intervention and control groups at six months postpartum
or later (biochemically validated or self-report). The rationale for this
two-pronged approach, was that by considering BCTs in light of their
overall frequency, we might identify techniques most likely to be fea-
sible, acceptable and fit for purpose.
We also extracted data concerning characteristics of trial partici-
pants, details of the intervention and control, smoking status outcomes
and data on intervention fidelity (adherence to the protocol, accept-
ability, compliance) in order to consider BCTs which might be most
effective and suitable for postpartum relapse interventions and how
these interventions might be best delivered. Data synthesis was narra-
tive.
3. Results
3.1. Results of the search
The inclusion of RCTs is summarised in Fig. 1. Electronic searching
identified 636 records, 88 duplicate references were removed, resulting
in 548 references for title and abstract screening. From these records,
72 relevant full text articles were identified (48 unique trials). Hand-
searching identified a further 69 relevant trials (after removal of du-
plicates). In total, articles from 117 studies were retrieved for full text
assessment with the final inclusion of 32 primary RCTs (106 articles :
Supplementary Table 1) which satisfied all inclusion criteria (Allen,
Allen, Lunos, & Tosun, 2016; Brandon, Simmons, Meade, et al., 2012;
Cummins, Tedeschi, Anderson, & Zhu, 2016; Edwards & Sims-Jones,
1997; El-Mohandes, El-Khorazaty, Kiely, & Gantz, 2011; Ershoff, Quinn,
& Mullen, 1995; Forray, Gilstad-Hayden, Sofuoglu, & Yonkers, 2016;
Forray & Waters, 2015; Hajek, West, Lee, et al., 2001; Hannover,
Thyrian, Roske, et al., 2009; Jimenez-Muro, Nerin, Samper, et al., 2013;
Johnson, Ratner, Bottorff, Hall, & Dahinten, 2000; Kendrick, Zahniser,
Miller, et al., 1995; Kientz & Kupperschmidt, 2005;Levine, Cheng,
Marcus, Kalarchian, & Emery, 2016; Lillington, Royce, Novak,
Ruvalcaba, & Chlebowski, 1995; McBride et al., 1999; McBride,
Baucom, Peterson, et al., 2004; Morasco, Dornelas, Fischer, Oncken, &
Lando, 2006; Mullen, DiClemente, & Bartholomew, 2001; Pbert,
Ockene, Zapka, et al., 2004; Petersen, Handel, Kotch, Podedworny, &
Rosen, 1992; Polanska, Hanke, Sobala, & Lowe, 2004; Pollak, Fish,
Lyna, et al., 2016; Reitzel, Vidrine, Businelle, et al., 2010; Ruger,
Weinstein, Hammond, Kearney, & Emmons, 2008; Secker-Walker,
Solomon, Flynn, et al., 1995; Strecher et al., 2000; Secker-Walker,
Solomon, Flynn, Skelly, & Mead, 1998; Suplee, 2005; Thornton, 1997;
Winickoff et al., 2010).
3.2. Characteristics of all included trials
The details of participants, intervention, comparison group, out-
come measures, main findings and BCTs identified are described in
Supplementary Table 2. The majority of studies (25 trials) were con-
ducted in the USA,(Allen et al., 2016; Brandon et al., 2012; Cummins
et al., 2016; El-Mohandes et al., 2011; Ershoff et al., 1995; Forray et al.,
2016; Forray & Waters, 2015; Kendrick et al., 1995; Kientz &
Kupperschmidt, 2005; Levine et al., 2016; Lillington et al., 1995;
McBride et al., 1999; McBride et al., 2004; Morasco et al., 2006; Mullen
et al., 2001; Pbert et al., 2004; Petersen et al., 1992; Pollak et al., 2016;
Reitzel et al., 2010; Ruger et al., 2008; Secker-Walker et al., 1995;
Secker-Walker et al., 1998; Strecher et al., 2000; Suplee, 2005;
Winickoff, Healey, Regan, et al., 2010) two in Canada,(Edwards & Sims-
Jones, 1997; Johnson et al., 2000) two in the UK,(Hajek et al., 2001;
Thornton, 1997) and three elsewhere in Europe (Germany, Spain and
Poland)(Hannover et al., 2009; Jimenez-Muro et al., 2013; Polanska
et al., 2004); all notably high income countries. Less than a third of
interventions targeted lower socioeconomic groups or ethnic minorities
(El-Mohandes et al., 2011; Kientz & Kupperschmidt, 2005; Levine et al.,
2016; Lillington et al., 1995; Morasco et al., 2006; Reitzel et al., 2010;
Ruger et al., 2008; Secker-Walker et al., 1998; Suplee, 2005; Thornton,
1997).
Interventions were heterogeneous, differing in intervention content,
mode of delivery, and population. Thirteen trials included mixed po-
pulations of pregnant smokers and quitters (Cummins et al., 2016;
Edwards & Sims-Jones, 1997; El-Mohandes et al., 2011; Hajek et al.,
2001; Kendrick et al., 1995; Lillington et al., 1995; McBride et al., 1999;
Morasco et al., 2006; Pbert et al., 2004; Petersen et al., 1992; Polanska
et al., 2004; Ruger et al., 2008; Strecher et al., 2000); eleven included
pregnant quitters (Brandon et al., 2012; Ershoff et al., 1995; Forray
et al., 2016; Forray & Waters, 2015; Kientz & Kupperschmidt, 2005;
Levine et al., 2016; Pollak et al., 2016; Reitzel et al., 2010; Secker-
Walker et al., 1995; Secker-Walker et al., 1998; Suplee, 2005); two
included mixed populations of postpartum smokers and quitters
(Hannover et al., 2009; Jimenez-Muro et al., 2013); two included
postpartum quitters (Allen et al., 2016; Johnson et al., 2000); three
included pregnant women and partners (McBride et al., 2004; Mullen
et al., 2001; Thornton, 1997); and one included postpartum women and
partners (Winickoff et al., 2010). Interventions in most trials (n=21)
consisted of face-to-face or telephone advice (counselling, cognitive
behavioural therapy, motivational interviewing) plus additional sup-
port (mainly written self-help materials), with the remainder using:
counselling alone (El-Mohandes et al., 2011; Secker-Walker et al., 1995;
Secker-Walker et al., 1998); self-help materials alone (Brandon et al.,
2012; Mullen et al., 2001; Petersen et al., 1992; Strecher et al., 2000);
oral progesterone (Allen et al., 2016; Forray et al., 2016); mobile phone
alerts (Forray & Waters, 2015); incentives plus counselling and sup-
porting materials (Lillington et al., 1995). Interventions were delivered
by a wide range of clinical staff, pregnancy specialists, counsellors or
researchers in either home or clinic settings. The intensity, duration,
and time between intervention sessions varied widely from the provi-
sion of a single session to a maximum of 14 sessions provided up to
9months postpartum. Only two trials followed up participants beyond
12months postpartum (Hannover et al., 2009; Secker-Walker et al.,
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1995). We found no clear pattern as to which modes of delivery and
timings of intervention contact would be best used to deliver inter-
vention components most effectively.
Smoking status was validated in at least a sample of the population
at a particular time point in 26 trials, but six trials only used self-report
data (Edwards & Sims-Jones, 1997; Forray & Waters, 2015; Hannover
et al., 2009; Kientz & Kupperschmidt, 2005; Polanska et al., 2004;
Thornton, 1997). Many trials reported some fidelity and/or accept-
ability issues, and we considered 10 trials as having reported major
intervention fidelity and/or acceptability concerns,(Edwards & Sims-
Jones, 1997; Hajek et al., 2001; Hannover et al., 2009; Johnson et al.,
2000; Kendrick et al., 1995; Kientz & Kupperschmidt, 2005; McBride
et al., 1999; Morasco et al., 2006; Pbert et al., 2004; Thornton, 1997)
which may have influenced intervention effectiveness. These trials
highlighted issues of low recruitment, low level of intervention im-
plementation, low level of uptake of the intervention, or high dropout
rates. There was no distinct pattern as to which specific components of
interventions had been most affected by fidelity and/or acceptability,
since this level of detail was often not reported. Some trials made no
reference, or minor reference, to fidelity related issues suggesting there
may also have been some underreporting of concerns relating to pro-
tocol adherence, acceptability, or compliance.
3.3. Characteristics of long-term effective trials
We found six long-term effective trials demonstrating a statistically
significant difference in smoking abstinence between the intervention
and control groups at six months postpartum or later (Brandon et al.,
2012; Cummins et al., 2016; Hannover et al., 2009; McBride et al.,
1999; Mullen et al., 2001; Reitzel et al., 2010). Five of these trials were
conducted in the USA and one in Germany (Hannover et al., 2009).
Three trials targeted abstinent pregnant women,(Brandon et al., 2012;
Mullen et al., 2001; Reitzel et al., 2010) one of which also included
partners,(Mullen et al., 2001) two trials targeted mixed populations of
pregnant smokers and quitters (Cummins et al., 2016; McBride et al.,
1999) and one trial included postpartum smokers and quitters
(Hannover et al., 2009). Four out of six interventions included an ele-
ment of one-to-one counselling plus the provision of self-help materials,
whilst two interventions (Brandon et al., 2012; Mullen et al., 2001)
provided only posted self-help educational materials. Control groups
received a less intensive intervention or usual care. All long-term ef-
fective interventions took place in home settings and were largely de-
livered remotely (telephone calls, posted or emailed materials) using a
variety of intensities and durations. Where counselling was in-
corporated into the intervention, this was provided by specialist
smoking cessation trained staff or by general trained counsellors. All
but one of these trials (Hannover et al., 2009) reported some bio-
chemical validation of outcome. Two long-term effective trials
(Hannover et al., 2009; McBride et al., 1999) reported intervention fi-
delity and/or acceptability concerns: low adherence to motivational
interviewing by trained counsellors (Hannover et al., 2009); or low
levels of engaging women in smoking related issues in counselling calls
Fig. 1. Flow diagram.
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(McBride et al., 1999) Had these issues not been present, it is possible
that the intervention effect may have been stronger.
3.4. Behaviour change techniques in trials and those characterised as
‘promising’
BCTs targeting improvements to smoking behaviour, that we iden-
tified from intervention descriptions in our included trials, are sum-
marised in Table 1. BCTs for each individual trial are shown in Sup-
plementary Table 2 (definitions of BCT codes are in Table 1). A total of
45 of the 93 BCTs from the BCTTv1 were identified. The BCTTv1 or-
ganises 93 individual BCTs into 16 different groups according to simi-
larity of individual BCT components (Michie et al., 2013). All groups
were present in our included trials, with the exception of the group
related to ‘scheduled consequences’ (concerning punishments and costs
versus rewards). The number of BCTs identified in individual inter-
ventions ranged from one to 19, with an average of 7.7 BCTs per in-
tervention. Focusing only on long-term effective interventions,
(Brandon et al., 2012; Cummins et al., 2016; Hannover et al., 2009;
McBride et al., 1999; Mullen et al., 2001; Reitzel et al., 2010) the
number of BCTs identified ranged from five to 19 with an average of 11
BCTs per intervention. The most prevalent BCTs in all included trials
(coded in ≥25% interventions) were: ‘problem solving’ (n=27); ‘in-
formation about social and environmental consequences' (n=27); ‘so-
cial support (unspecified)’ (n=25); ‘information about health con-
sequences' (n=18); ‘credible source’ (n=17); ‘instruction on how to
perform a behaviour’ (n=11); and ‘reduce negative emotions' (n=9).
For example, many trials gave information to participants on the health
effects of smoking, or effects of exposure to environmental tobacco
smoke.
We characterised six BCTs as ‘promising’, or most likely to enhance
effectiveness of interventions to maintain smoking abstinence. The
BCTs which we identified as ‘promising’ were: ‘problem solving’ in all
(i.e., 100%) of long-term effective interventions; ‘information about
health consequences’ (100%); ‘information about social and environ-
mental consequences’ (100%); ‘social support’ (100%); ‘reduce negative
emotions’ (50%); and ‘instruction on how to perform a behaviour’
(33%). If we were to remove the two trials (Hannover et al., 2009;
McBride et al., 1999) which reported fidelity and/or acceptability
concerns in our analysis, these six BCTs would still meet our definition
of ‘promising’, or most likely to be effective.
Table 1
Frequency of BCTs identified in smoking relapse interventions.
BCT code BCT label BCT in all studies; n (%); Max n=32 BCT in ‘long-term effective’# studies; n (%); Max n=6
1.1 Goal setting (behavior) 5 (16) 1 (17)
1.2 Problem solving 27 (84) 6 (100) *
1.4 Action planning 1 (3) 0 (0)
1.5 Review behavior goal(s) 4 (13) 0 (0)
1.6 Discrepancy between current behavior and goal 1 (3) 1 (17)
1.7 Review outcome goal(s) 2 (6) 0 (0)
1.8 Behavioural contract 2 (6) 0 (0)
1.9 Commitment 3 (9) 1 (17)
2.2 Feedback on behavior 1 (3) 0 (0)
2.3 Self-monitoring of behavior 3 (9) 0 (0)
2.6 Biofeedback 4 (13) 0 (0)
3.1 Social support (unspecified) 25 (78) 6 (100) *
3.2 Social support (practical) 3 (9) 1 (17)
3.3 Social support (emotional) 3 (9) 1 (17)
4.1 Instruction on how to perform a behavior 11 (34) 2 (33) *
4.2 Information about antecedents 2 (6) 0 (0)
4.3 Re-attribution 1 (3) 1 (17)
5.1 Information about health consequences 18 (56) 6 (100) *
5.3 Information about social and environmental consequences 27 (84) 6 (100) *
5.6 Information about emotional consequences 1 (3) 1 (17)
6.1 Demonstration of the behavior 2 (6) 1 (17)
6.2 Social comparison 4 (13) 3 (50)
7.1 Prompts/cues 4 (13) 1 (17)
8.1 Behavioural practice/ rehearsal 2 (6) 0 (0)
8.2 Behavior substitution 5 (16) 2 (33)
9.1 Credible source 17 (53) 1 (17)
9.2 Pros and cons 7 (22) 3 (50)
9.3 Comparative imagining of future outcomes 1 (3) 0 (0)
10.1 Material incentive (behavior) 1 (3) 0 (0)
10.2 Material reward (behavior) 1 (3) 0 (0)
10.3 Non-specific reward 1 (3) 0 (0)
10.4 Social reward 6 (19) 2 (33)
10.7 Self-incentive 1 (3) 0 (0)
11.1 Pharmacological support 3 (9) 1 (17)
11.2 Reduce negative emotions 9 (28) 3 (50) *
12.1 Restructuring the physical environment 2 (6) 1 (17)
12.2 Restructuring the social environment 2 (6) 1 (17)
12.3 Avoidance/reducing exposure to cues for the behavior 4 (13) 2 (33)
12.5 Adding objects to the environment 4 (13) 2 (33)
13.1 Identification of self as role model 3 (9) 2 (33)
13.2 Framing/reframing 7 (22) 2 (33)
13.5 Identity associated with changed behavior 2 (6) 2 (33)
15.1 Verbal persuasion about capability 7 (22) 1 (17)
15.3 Focus on past success 1 (3) 1 (17)
16.2 Imaginary reward 3 (9) 2 (33)
# p < .05 in intervention vs control at ≥6months postpartum; *BCTs identified as ‘promising’.
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4. Discussion
This review is the first study, to our knowledge, to identify BCTs
most promising for preventing postpartum smoking relapse. We iden-
tified a wide range of BCTs, finding an average of 7.7 BCTs per inter-
vention for all included trials, and an average of 11 BCTs per inter-
vention for long-term effective trials. There is a possibility that the
effectiveness of interventions might be improved by incorporating more
BCTs, implying more ‘complex’ interventions. We found six ‘promising’
BCTs, which were both frequently occurring and present in interven-
tions that demonstrated long-term effectiveness of sustained smoking
abstinence postpartum. These were: ‘problem solving’ which included
advice on smoking relapse prevention; ‘information about health con-
sequences’; ‘information about social and environmental consequences’
such as the effects of second-hand smoke; ‘social support’ from a partner
or other supporter; ‘reduce negative emotions’ including stress man-
agement; and ‘instruction on how to perform a behaviour’ including
skills training. Previous studies have identified effective BCTs using the
smoking specific taxonomy (West et al., 2010) for smoking cessation in
pregnancy (Lorencatto et al., 2012); and cessation for smokers in gen-
eral (Lorencatto et al., 2013; West et al., 2010). This taxonomy has
largely been superseded by the BCTTv1 designed for use in all beha-
viour change interventions (Michie et al., 2013). More recently,
Campbell (Campbell et al., 2018) identified BCTs for smoking cessation
in pregnancy based on combining the smoking specific taxonomy with
the BCTTv1. However, they only included trials from a single Cochrane
review (Chamberlain et al., 2017). Our results concur with those of
Campbell et al. in finding the following BCTs to be potentially effective,
based on their presence in two or more effective interventions: ‘in-
formation about consequences’; ‘problem solving’; ‘social support’ and
‘reduce negative emotions’. In total their review found 23 potentially
effective techniques, but did not find the BCT ‘instruction on how to
perform a behaviour’ to be present in effective interventions. However,
providing advice on stop smoking medication and changing routine,
have been identified as important BCTs for general smokers (smokers
not necessarily pregnant or postpartum) (Lorencatto et al., 2013; West
et al., 2010). Differences in our findings may be since these previous
reviews were focused on smoking cessation, whilst we aimed to find
BCTs effective for relapse prevention in the postpartum period.
Pregnant and postpartum smokers tend to be of a lower socio-
economic status, less well educated and have lower levels of support
(Chamberlain et al., 2017; Orton et al., 2018). Future interventions and
their BCT components need to be tailored to address the specific needs
and cultural identity of these high-risk groups. Women who return to
smoking postpartum may be less aware of the detrimental effects to the
health of the baby caused by their return to smoking (Orton et al.,
2018). This suggests the BCTs we identified concerning provision of
‘information about health consequences’ and ‘information about social
and environmental consequences’, would be fundamental to the success
of an intervention to prevent postpartum smoking relapse. Having
greater social or partner support is known to be a key facilitator to
prevent relapse (Flemming et al., 2015; Notley et al., 2015; Orton et al.,
2018) and our finding of the importance in providing enhanced social
support is consistent with this. Only four trials included in this review
specifically engaged with partner groups. A review of postpartum re-
lapse strategies concluded that more programmes should include a
woman's partner and her wider social support network (Fang et al.,
2004). We found BCTs prompting problem solving and providing gui-
dance on how to maintain smoking abstinence to be ‘promising’, cor-
responding well with literature finding predictors for relapse include
having a lower confidence to remain abstinent postpartum (Orton et al.,
2018). Other predictors for relapse are experiencing higher levels of
stress, depression and anxiety, and women who smoke are more likely
to use substances in response to these circumstances (Chamberlain
et al., 2017; Orton et al., 2018). Our finding of the importance in in-
cluding the BCT to ‘reduce negative emotions’ might therefore improve
the chances of success of an intervention to maintain smoking ab-
stinence.
Many factors influence the effectiveness of BCTs within interven-
tions in addition to the content; including intervention fidelity, ac-
ceptability, the mode of delivery, setting, duration, intensity and
characteristics of the provider (Lorencatto et al., 2012; Michie, Fixsen,
Grimshaw, & Eccles, 2009). Considering all of our included trials, we
found no clear pattern relating these characteristics to the effectiveness
of BCTs although, as noted by others, descriptions of intervention
characteristics and fidelity related issues were limited in published
papers (Michie et al., 2009). Long-term effective interventions that we
identified all provided self-help support, and four out of six long-term
effective trials combined self-help with counselling. For continued
smoking abstinence postpartum, Chamberlain (Chamberlain et al.,
2017) found some evidence for positive effects of health education,
counselling and incentives. For smoking cessation in pregnancy, self-
help interventions, including those delivered digitally (by computer or
as text messages), have been found to be effective. (Griffiths et al.,
2018; Naughton, Prevost, & Sutton, 2008). Self-help provided as
written or electronic support, or as part of counselling, may be fa-
vourable modes of delivery for BCTs and worthy of further research.
Long-term effective interventions included in this study were delivered
in home settings and mostly delivered remotely (telephone calls, posted
or emailed materials). This suggests effective interventions might be
delivered relatively cost-effectively. However, fidelity issues relating to
protocol adherence, poor acceptability or participant compliance were
evident in two of these trials,(Hannover et al., 2009; McBride et al.,
1999) which may have limited intervention effectiveness. Future in-
terventions need to consider issues of implementation and acceptability
in this population, who may be challenging to engage.
Potential limitations to this review included the heterogeneity of
participants, types of interventions and outcomes. Therefore, as in si-
milar BCT content reviews,(Campbell et al., 2018; Lorencatto et al.,
2012) we did not attempt meta-analysis. As noted elsewhere in the
literature,(Michie et al., 2009) the level of detail needed for BCT coding
was often not present in published intervention descriptions. In prac-
tice, interventions may have used more BCTs than those reported. We
did not contact study authors, but did address this by taking an in-
clusive approach in our coding, including BCTs coded as probably
present (+) in addition to those coded as definitely (++) present
(www.bct-taxonomy.com). We included a second independent coder
for 10% of data extraction and involved a third reviewer where ne-
cessary to resolve discrepancies and to ensure any relevant BCTs had
been correctly identified. Unfortunately we were unable to fully du-
plicate screening and data extraction due to limited resources. We did
not assess risk of bias, as our main aim was to identify any potentially
relevant BCTs, but we did describe any reported fidelity and/or ac-
ceptability issues, to consider how BCTs might be best delivered. As in
other reviews (Campbell et al., 2018) we did not compare BCTs within
effective and non-effective interventions. No trials reported a negative
intervention effect and using this approach may have limited the
number of potentially relevant BCTs. Measures of study effectiveness
are also acknowledged to be ambiguous, since statistical significance is
dependent on a wide range of factors, such as sample size (Peters, de
Bruin, & Crutzen, 2015). We cannot say with certainty that the presence
of individual BCTs, demonstrates any causal relationship with trial
outcome, but their repeated presence across long-term effective trials
suggests they may be more promising approaches for future interven-
tion content.
Not all trials validated smoking abstinence biochemically, although
a Cochrane review reported similar effect sizes in pregnancy trials
which were validated and trials which were not (Chamberlain et al.,
2017). All trials were conducted in high-income countries with the
majority conducted in the USA; which may mean findings would not be
generalizable to other countries or contexts. Smoking in pregnancy is
reducing in higher income countries but increasing in low and middle-
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income countries (Chamberlain et al., 2017; Coleman et al., 2015) and
no such countries met the inclusion criteria for this review. However,
this may be since we excluded articles not published in English. The
majority of included trials were targeted to general populations of
pregnant or postpartum women, rather than populations of ethnic
minorities or lower socioeconomic groups, where smoking prevalence is
higher. Further research with these specific groups would be beneficial
and might identify further relevant BCTs, such as BCTs concerning
identity specific to different populations. Difficulty in adapting to a new
mothering identity has been identified as a key factor in prompting
return to smoking postpartum (Flemming et al., 2015; Notley et al.,
2015). We did not identify any trials that focused on nicotine replace-
ment therapy (NRT) or were recent enough to include more novel ap-
proaches such as e-cigarettes. Evidence suggests that e-cigarettes are
significantly less harmful than smoking tobacco and many smokers use
e-cigarettes as an aid to quit (DoH, 2017; McNeill, Brose, Calder, Bauld,
& Robson, 2018). There is some evidence that for pharmacological in-
terventions for smoking cessation in pregnancy, behavioural support in
combination with NRT might be helpful (Coleman et al., 2015).
Strengths to this review included the systematic approach to iden-
tifying relevant interventions and the application of the most recent
behaviour change technique taxonomy (Michie et al., 2013). We
characterised BCTs as ‘promising’ if present in long-term effective in-
terventions and where frequency in all included trials (regardless of
effectiveness) was high. We were therefore able to consider ‘promising’
BCTs in light of their overall frequency in interventions relevant to this
population, giving an indication of the ease by which these BCTs might
be incorporated into interventions, their suitability to the setting, fea-
sibility and acceptability. This is one of the first systematic reviews of
BCTs specifically to prevent return to smoking postpartum and these
results further our understanding of what behavioural support might be
effective. Future research could compare interventions with different
combinations of BCTs, or could compare BCTs in intervention and
control groups. The identification and testing of BCTs in future post-
partum relapse prevention interventions in a more diverse range of
countries, with more diverse populations, and incorporating more novel
components such as e-cigarettes would be beneficial to research and
future practice. Identifying six specific BCTs as promising components
for postpartum smoking relapse prevention highlights the need to
customise support for this particular population. Further research by
our team will explore these BCT components through qualitative re-
search with postpartum ex-smokers in order to develop a prototype
intervention for maintenance of smoking abstinence postpartum (MRC
PHIND grant ref.: MR/P016944/1).
5. Conclusions
We identified six promising BCTs to prevent postpartum smoking
relapse based on a structured systematic review of published available
evidence. Future interventions should consider the inclusion of BCTs
addressing problem solving and how to maintain abstinent behaviour,
information on health and other consequences of smoking, reducing
negative emotions and improving the likelihood of smoking abstinence
through the provision of social support.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.addbeh.2018.12.031.
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